FCFan Chao

Fan Chao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fan Chao has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hetrombopag in China: expanding indications, comparative positioning, and risk management - a critical narrative review

    by Fan Chao, Rongwei Li

    1 Thrombopoietin receptor agonists (TPO-RAs) have changed the management of immune thrombocytopenia (ITP) and bone-marrow failure by stimulating platelet production rather than suppressing immunity...

  • Open Access

    Hierarchically enhanced feature fusion and loss prevention for prostate segmentation on micro-ultrasound images

    by Jianuo Huang, Fan Chao, Peng Lai, Zhibing Xu

    Micro-ultrasound (micro-US) provides superior resolution compared to conventional ultrasound, enabling improved visualization of anatomical structures and supporting more accurate prostate cancer detection. However, prostate segmentation in micro-US remains challenging due to imaging artifacts and indistinct tissue boundaries. While recent Transformer-based UNet models have achieved promising results, they still suffer from inefficient multi-scale feature fusion, limited contextual modeling, and inadequate integration of local and global information. To address these issues, we propose HEFFLPNet, a Transformer-based UNet architecture that introduces hierarchically enhanced feature fusion and loss prevention mechanisms. HEFFLPNet integrates three novel modules: the Tri-Cross Attention with Feature Enhancement (TriCAFE) module for strengthening semantic consistency across skip connections, the Multi-Scale Prediction Map Attention (MSPMA) module for scale-specific feature refinement, and the Upsample Fusion Attention (UpFA) module for attention-guided fusion of spatial details. The model adopts annotation-guided binary cross entropy (AG-BCE) loss and deep supervision across multiple scales, building on the MicroSegNet framework. We evaluate HEFFLPNet on two datasets: the micro-US dataset (55 training and 20 testing cases) and the CCH-TRUSPS dataset. Our model achieves a Dice coefficient of 0.938 and a Hausdorff distance of 2.12 mm on the micro-US dataset, and 0.914 Dice and 3.63 mm HD95 on CCH-TRUSPS, outperforming existing state-of-the-art methods. These results demonstrate the effectiveness and generalization ability of HEFFLPNet in segmenting prostate structures under challenging ultrasound conditions.


  • Open Access

    Cell-free DNA as a Promising Diagnostic Biomarker in Prostate Cancer: A Systematic Review and Meta-Analysis

    by Cong Zhang, Fan Chao, Shiyu Wang, Dunsheng Han, Gang Chen

    Objective. The detection of cell-free DNA (cfDNA) as a part of “liquid biopsy” of prostate cancer (PCa) has been widely explored. However, its diagnostic value for PCa remains controversial. Based on the data from the latest literature published in the past decade, the present review was conducted to clarify the diagnostic value of cfDNA in PCa. Methods. The related studies were systematically searched in the databases of PubMed, Embase, Web of Science, and Cochrane Library from January 1, 2010 to December 1, 2020. Sensitivity (SEN), specificity (SPE), and other relative parameters were pooled using a random model. Results. 14 eligible studies with 1049 PCa patients and 973 controls were selected based on the inclusion and exclusion criteria. Results demonstrated that cfDNA showed favorable SPE (0.89, 95% CI: 0.79, 0.94) but unsatisfied SEN (0.56, 95% CI: 0.43, 0.68) in the PCa diagnosis. The positive likelihood ratios (PLR), negative likelihood ratios (NLR), and diagnostic odds ratios (DOR) were 5.1 (95% CI: 3.1, 8.5), 0.49 (95% CI: 0.39, 0.63), and 10 (95% CI: 6, 17), respectively. The summary receiver operating characteristic graph (SROC) with an area under the curve (AUC) of 0.80 (95% CI: 0.76, 0.83) was constructed which indicated favorable diagnostic accuracy for PCa. Results of the subgroup analysis and metaregression analysis reminded “ethnicity” and “methylation” might be sources of heterogeneity. The potential publication bias was not found using Deek’s funnel plot asymmetry test ( ). Conclusions. Our meta-analysis illustrated that the cfDNA could undertake a promising role in the PCa diagnosis.


  • Circular RNA circPFKP promotes cell proliferation by activating IMPDH2 in prostate cancer

    by Shiyu Wang, Fan Chao, Cong Zhang, Dunsheng Han, Guoxiong Xu, Gang Chen